GPs Warn of Neurodiversity Tsunami as ADHD Prescribing Rights Expand

Preparation for Neurodiversity Surge

GPs in New Zealand are preparing for a surge in demand as new rules expand their ability to diagnose and prescribe ADHD. The move aims to increase access to treatment but comes with concerns over workload and cost implications.

Since GPs were stripped of their authority to prescribe stimulants in 1999, only paediatricians and psychiatrists have been permitted to diagnose ADHD and prescribe drugs. With the recent rule change, GPs and nurse practitioners can now diagnose and prescribe for adults, but without government funding or training requirements, they face significant challenges.

Entrepreneur Freddie Bennett, not diagnosed with ADHD until his mid-30s, shares his journey from struggling with mental health issues to harnessing his neurodiverse strengths. His experiences highlight the importance of proper diagnosis and support for individuals with ADHD.

Despite the new rules, there are concerns about the availability of ADHD medication due to ongoing shortages expected to continue throughout 2023. Advocates emphasize the need for increased public access to diagnosis and treatment, but currently, many face high costs and fragmented care pathways.

Predicting a 'neurodiversity tsunami,' Tauranga entrepreneur Freddie Bennett and his wife, developmental paediatrician Dr Sarah Moll, have set up an ADHD clinic in Tauranga. They warn that stretched GPs may not be able to provide the necessary wraparound support required for individuals with ADHD.

Parents and advocates continue to push for improved public services, emphasizing that diagnosis is just the first step. Without comprehensive support systems, many risk long-term mental health consequences and diminished future potential due to untreated ADHD.